| High incidence of traumatic spinal cord injury in Estonia L Sabre, G Pedai, T Rekand, T Asser, Ü Linnamägi, J Kõrv Spinal cord 50 (10), 755-759, 2012 | 77 | 2012 |
| Mortality and causes of death after traumatic spinal cord injury in Estonia L Sabre, T Rekand, T Asser, J Kõrv The Journal of Spinal Cord Medicine 36 (6), 687-694, 2013 | 50 | 2013 |
| Traumatic spinal cord injury in two E uropean countries: why the differences? L Sabre, EM Hagen, T Rekand, T Asser, J Kõrv European journal of neurology 20 (2), 293-299, 2013 | 37 | 2013 |
| miR‐30e‐5p as predictor of generalization in ocular myasthenia gravis L Sabre, P Maddison, SH Wong, G Sadalage, PA Ambrose, GT Plant, ... Annals of clinical and translational neurology 6 (2), 243-251, 2019 | 36 | 2019 |
| Health-related quality of life in patients with traumatic spinal cord injury in Estonia A Kivisild, L Sabre, T Tomberg, T Ruus, J Kõrv, T Asser, Ü Linnamägi Spinal Cord 52 (7), 570-575, 2014 | 35 | 2014 |
| Circulating microRNA miR-21-5p, miR-150-5p and miR-30e-5p correlate with clinical status in late onset myasthenia gravis L Sabre, P Maddison, G Sadalage, PA Ambrose, AR Punga Journal of neuroimmunology 321, 164-170, 2018 | 33 | 2018 |
| Neurosyphilis as a great imitator: a case report L Sabre, M Braschinsky, P Taba BMC Research Notes 9, 1-4, 2016 | 30 | 2016 |
| Brain activation in the acute phase of traumatic spinal cord injury L Sabre, T Tomberg, J Kõrv, J Kepler, K Kepler, Ü Linnamägi, T Asser Spinal Cord 51 (8), 623-629, 2013 | 30 | 2013 |
| Impact of fatal cases on the epidemiology of traumatic spinal cord injury in Estonia L Sabre, S Remmer, A Adams, M Väli, T Rekand, T Asser, J Kõrv European journal of neurology 22 (5), 768-772, 2015 | 29 | 2015 |
| Thymectomy lowers the myasthenia gravis biomarker miR-150-5p CJ Molin, L Sabre, CA Weis, T Punga, AR Punga Neurology: Neuroimmunology & Neuroinflammation 5 (3), e450, 2018 | 28 | 2018 |
| Brain activation in the chronic phase of traumatic spinal cord injury L Sabre, T Tomberg, J Kõrv, J Kepler, K Kepler, Ü Linnamägi, T Asser Spinal Cord 54 (1), 65-68, 2016 | 28 | 2016 |
| Circulating miRNAs as potential biomarkers in myasthenia gravis: tools for personalized medicine L Sabre, T Punga, AR Punga Frontiers in immunology 11, 511028, 2020 | 27 | 2020 |
| Epidemiology of traumatic spinal cord injury in Estonia L Sabre Brain activation in the acute phase of traumatic spinal cord injury. Tartu, 2013 | 21 | 2013 |
| Cognitive dysfunction in mice with passively induced MuSK antibody seropositive myasthenia gravis L Sabre, A Evoli, AR Punga Journal of the neurological sciences 399, 15-21, 2019 | 19 | 2019 |
| Diversity in mental fatigue and social profile of patients with myasthenia gravis in two different Northern European countries L Sabre, E Westerberg, M Liik, AR Punga Brain and Behavior 7 (4), e00653, 2017 | 17 | 2017 |
| Circulating microRNA plasma profile in MuSK+ myasthenia gravis L Sabre, JT Guptill, M Russo, VC Juel, JM Massey, JF Howard Jr, ... Journal of neuroimmunology 325, 87-91, 2018 | 14 | 2018 |
| A new risk factor for traumatic spinal cord injury L Sabre, J Harro, D Eensoo, M Vaht, V Kabel, M Pakkanen, T Asser, ... Journal of neurotrauma 33 (21), 1946-1949, 2016 | 9 | 2016 |
| New onset generalized myasthenia gravis evolving following SARS-CoV-2 infection K Jõgi, L Sabre, M Rosental, AR Leheste, J Vilisaar Covid 2 (4), 464-471, 2022 | 5 | 2022 |
| Seljaajutrauma ja autonoomne närvisüsteem L Sabre, J Kõrv, T Asser, T Rekand Eesti Arst 90 (3), 129-134, 2011 | 3 | 2011 |
| Headaches after traumatic spinal cord injury in Estonia L Sabre, M Rugo, T Asser, J Korv, M Braschinsky Cephalalgia 36 (5), 403-412, 2016 | 2 | 2016 |
